Miller Global Investments’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.19M Hold
20,632
0.98% 21
2026
Q1
$1.25M Sell
20,632
-18
-0.1% -$1.05K 1.15% 22
2025
Q4
$1.11M Buy
+20,650
New +$993K 1.01% 25

Other funds holding BMY

Miller Global Investments's BMY Position: Q2 2026 in Review

Miller Global Investments held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 20,632 shares worth $1.19M. The position accounts for 0.98% of the portfolio, ranked #21.

Miller Global Investments first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.25M in Q1 2026. 1,399 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Miller Global Investments held 20,632 shares of Bristol-Myers Squibb worth $1.19M as of Q2 2026.
  • Miller Global Investments left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up 0.98% of Miller Global Investments's portfolio in Q2 2026, its #21 holding.
  • Miller Global Investments first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
  • Miller Global Investments's Bristol-Myers Squibb position peaked at $1.25M in Q1 2026.
  • 1,399 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Miller Global Investments's 13F filing for Q2 2026, filed 1 Jul 2026.